Latest Breaking News On - Mohammed syed - Page 10 : comparemela.com
E-Mail
BOSTON - A gene called KRAS is one of the most commonly mutated genes in all human cancers, and targeted drugs that inhibit the protein expressed by mutated KRAS have shown promising results in clinical trials, with potential approvals by the U.S. Food and Drug Administration anticipated later this year. Unfortunately, cancer cells often develop additional mutations that make them resistant to such targeted drugs, resulting in disease relapse. Now researchers led by a team at Massachusetts General Hospital (MGH) have identified the first resistance mechanisms that may occur to these drugs and identified strategies to overcome them. The findings are published in
BostonMassachusettsUnited-statesAmericanMustafa-sakhiSamuel-klempnerMohammed-syedGiulia-siravegnaAaron-hataMeagan-ryanJochen-lennerzChendi-li Share
Source: AP Photo/John Minchillo
Pfizer released some rather welcoming news on Wednesday, which Cortney reported on, that the Pfizer clinical trials on children aged 12-15 was 100 percent effective.
A press release from Pfizer noted that The companies plan to submit these data to the FDA and EMA for a requested amendment to the Emergency Use Authorization of BNT162b2 and that there also is an ongoing study in children aged 6 months-11 years. The 5 to 11 year-old cohort started dosing last week and the companies plan to initiate the 2 to 5 year-old cohort next week, the press release read.
Again, this is welcoming news. If you re worried it will give the teachers
United-statesWuhanHubeiChinaMassachusettsMaldenAmericanPaige-wallisRandi-weingartenBecky-pringleJoe-bidenJessica-dickler